Yu Shen

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial”.

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00613-1

N/A

5.1DataRank · unranked

163 citations

Benjamin D. Smith, Savitri Krishnamurthy, Wei Yang, Vicente Valero, Yu Shen +31 more

Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0029

N/A

1.4DataRank · unranked

34 citations

Tianyu Cai, Xia Li, Xiaoli Huang, Mai H. Bui, Joshua P. Plotnik +26 more

Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.33933

N/A

0.652DataRank · unranked

12 citations

Heather Lin, Yu Shen, Emilia J. Diego, Savitri Krishnamurthy, Wei Yang +32 more

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00722-1

N/A

0.550DataRank · unranked

18 citations

Nicole M. Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang, David L. Ramírez +6 more

Semiparametric additive risks model for interval-censored data

UNC Libraries(2021)10.17615/nhgk-1q61

N/A

0DataRank · unranked

62 citations

Jianwen Cai, Yu Shen, Donglin Zeng

Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients

Annals of Surgical Oncology(2021)10.1245/s10434-020-09542-y

N/A

0DataRank · unranked

31 citations

Marion E. Scoggins, Henry M. Kuerer, Savitri Krishnamurthy, Wei Yang, Ayşegül A. Şahin +9 more

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific Reports(2021)10.1038/s41598-021-01473-2

N/A

0DataRank · unranked

23 citations

Angela Marx, Diane D. Liu, Yu Shen, Hui Gao, James M. Reuben +9 more

Phase I safety and efficacy study of autophagy inhibition with hydroxychloroquine to augment the antiproliferative and biological effects of preoperative palbociclib plus letrozole for estrogen receptor-positive, HER2-negative metastatic breast cancer (MBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1067

N/A

0DataRank · unranked

3 citations

Danielle Kwiatkowski, Senthil Damodaran, Nicole M. Kettner, David L. Ramírez, Dan S. Gombos +5 more

Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction

Annals of Surgery(2023)10.1097/sla.0000000000005920

N/A

0DataRank · unranked

26 citations

Xiudong Lei, Weiguo He, Reshma Jagsi, Sharon H. Giordano, Grace L. Smith +5 more

Accommodating Time-Varying Heterogeneity in Risk Estimation under the Cox Model: A Transfer Learning Approach

Journal of the American Statistical Association(2023)10.1080/01621459.2023.2210336

N/A

0DataRank · unranked

22 citations

Yu Shen, Jing Ning, Ziyi Li

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0330

N/A

0DataRank · unranked

11 citations

Gaurav B. Chauhan, Ramakrishna Edupuganti, Takahiro Kogawa, Jihyun Park, Moises Tacam +20 more

Detection method has independent prognostic significance in the PLCO lung screening trial

Scientific Reports(2023)10.1038/s41598-023-40415-y

N/A

0DataRank · unranked

4 citations

Yu Shen, James P. Long

Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma

The Oncologist(2023)10.1093/oncolo/oyad317

N/A

0DataRank · unranked

3 citations

Wei Qaio, Yu Shen, Akshara Singareeka Raghavendra, Debasish Tripathy, Rachel M. Layman +1 more

Independent prognostic value of method of detection in lung cancer: Analysis of the PLCO lung screening trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e22526

N/A

0DataRank · unranked

0 citations

Yu Shen, James P. Long

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling

Research Square(2023)10.21203/rs.3.rs-3466989/v1

N/A

0DataRank · unranked

0 citations

Takeo Fujii, Jing Ning, Toshiaki Iwase, Jing Qin, Naoto T. Ueno +2 more

Biomarker trajectory for earlier detection of lung cancer

EBioMedicine(2024)10.1016/j.ebiom.2024.105377

N/A

0DataRank · unranked

10 citations

Samir Hanash, Iakovos Toumazis, Jody V. Vykoukal, Jennifer B. Dennison, Yu Shen +4 more

Survival outcomes after omission of surgery for ductal carcinoma in situ

npj Breast Cancer(2024)10.1038/s41523-024-00689-5

N/A

0DataRank · unranked

6 citations

Wenli Dong, Simona F. Shaitelman, Nina Tamirisa, Yu Shen, Isabelle Bedrosian +1 more

Longitudinal varying coefficient single-index model with censored covariates

Biometrics(2024)10.1093/biomtc/ujad006

N/A

0DataRank · unranked

0 citations

Jing Ning, Ying Xu, Ya‐Chen Tina Shih, Yu Shen, Liang Li +1 more

Conformal predictive intervals in survival analysis: a resampling approach

Biometrics(2025)10.1093/biomtc/ujaf063

N/A

0DataRank · unranked

3 citations

Jin Piao, Jing Ning, Yu Shen, Jing Qin

Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00732-z

N/A

0DataRank · unranked

2 citations

Wenli Dong, Yu Shen, Heather Lin, Simona F. Shaitelman, Gildy V. Babiera +2 more

Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling

Scientific Reports(2025)10.1038/s41598-025-90134-9

N/A

0DataRank · unranked

4 citations

Takeo Fujii, Jing Ning, Toshiaki Iwase, Jing Qin, Naoto T. Ueno +2 more

Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective

Surgery(2020)10.1016/j.surg.2020.04.052

N/A

0DataRank · unranked

44 citations

Laura J. Esserman, Eugene J. Koay, Anirban Maitra, Yu Shen, Kimberly S. Kirkwood +2 more

A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over time

Statistical Methods in Medical Research(2025)10.1177/09622802251320793

N/A

0DataRank · unranked

0 citations

Xuelin Huang, Ruosha Li, Yu Shen, Nicholas J. Short, Kapil N. Bhalla +1 more

Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes

Journal of Cancer(2020)10.7150/jca.40817

N/A

0DataRank · unranked

57 citations

Yan Lin, Isabelle Bedrosian, Yu Shen, Gildy V. Babiera, Simona F. Shaitelman +1 more

Identifying Preferred Breast Cancer Risk Predictors: A Holistic Perspective

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa181

N/A

0DataRank · unranked

3 citations

Yu Shen, Ya‐Chen Tina Shih, Ruth Etzioni

CoxPhLb: An R Package for Analyzing Length Biased Data under Cox Model

The R Journal(2020)10.32614/rj-2020-024

N/A

0DataRank · unranked

0 citations

Zhou Heng, Jing Ning, Duroux Diane, Yu Shen, Hyun Lee Chi